This resolution officially designates February 28, 2026, as Rare Disease Day to raise awareness and support efforts for those affected by rare diseases.
John Barrasso
Senator
WY
This resolution officially designates February 28, 2026, as "Rare Disease Day." It recognizes the millions of Americans affected by rare diseases and highlights the ongoing challenges in diagnosis, treatment, and research. The bill aims to raise awareness and support efforts to advance treatments and cures for these often serious and life-threatening conditions.
Senate Designates February 28, 2026, as Rare Disease Day to Boost Research and Diagnosis Awareness
This resolution officially marks February 28, 2026, as "Rare Disease Day," a move designed to shine a spotlight on the 30 million Americans living with conditions that affect fewer than 200,000 people each. Beyond just a date on the calendar, the resolution acknowledges the uphill battle these patients face, from the high cost of life-altering treatments to the simple struggle of finding a doctor who has even heard of their specific condition. By formalizing this day, the government aims to support the push for earlier diagnoses and more robust funding for the 95% of rare diseases that currently have no FDA-approved treatment.
The 1-in-10 Reality
While the term "rare" sounds like a fluke, the resolution points out a staggering reality: about 1 in 10 people in the U.S. is living with one of the 10,000 known rare diseases. For a parent of a child with an undiagnosed condition, this resolution is a nod to the "diagnostic odyssey"—the years spent bouncing between specialists and insurance hurdles. It explicitly recognizes the importance of the FDA’s Accelerating Rare Disease Cures (ARC) Program and the National Institutes of Health (NIH), which are tasked with speeding up the pipeline for new drugs. In 2025 alone, 23 of the 46 novel drugs approved were for rare diseases, and this resolution seeks to keep that momentum moving by keeping these issues on the national radar.
Breaking the Treatment Barrier
The resolution also celebrates the 43rd anniversary of the Orphan Drug Act, the legislative backbone that makes it financially viable for companies to develop treatments for small groups of patients. For a software developer with a rare autoimmune disorder or a construction worker with a unique blood condition, this isn't just bureaucracy; it’s about the incentives that lead to the medicine they need to stay on the job. By designating a specific day for awareness, the resolution encourages a global and national research effort to ensure that having a "rare" diagnosis doesn't mean being left behind by modern medicine.